This page contains a Flash digital edition of a book.
patent law 41 Hunting for innovations


From its head office on Surrey University’s research park in Guildford, a team of experts hunts for clever innovations that it can commercially exploit.


Angle plc is digging out ideas and know-how from universities and companies and polishing them up for successful commercial exploitation.


Angle’s formula means useful and valuable products are reaching consumers, rather than struggling to get out of the laboratory. The inventors get their share of the rewards and can carry on researching and developing other new products and technologies.


Most recently, Angle has become a commercially driven specialist medical diagnostics company with pioneering products in cancer diagnostics and foetal health.


Angle’s lead product is the


Parsortix cell separation device, which can capture very rare circulating tumour cells (CTCs) in cancer patient blood – even when there is less than one CTC in one billion healthy cells. The resulting liquid biopsy (simple blood test) enables the investigation of mutations in the patient’s cancer for personalised cancer care.


Angle has launched a product for the research market and has secured CE Mark regulatory approval for the clinical market in Europe. FDA approval is targeted for 2014.


Technologies that Angle has brought out of the laboratory and into – or heading towards – the marketplace in the past include:


b005 protecting innovation JR (1) PR.pdf 1 09/06/2014 14:37:10


• Novocellus: a test for use in IVF treatment, to allow clinical embryologists to test embryo viability before transfer back to the


mother. The technology was developed at the University of York.


• Geomerics: a patented system of geometric algebra, developed at Cambridge University, that makes computer games faster and more realistic.


• Provexis: a range of natural foods and drinks, including the fruit juice Sirco with a patented bioactive extract of tomato that reduces the risk of thrombosis, heart attack and stroke. Orginally developed at the Rowett Institute in Aberdeen.


• Acolyte Biomedica: a diagnostic test, BacLite, initially developed at the former government research laboratory at Porton Down, that can confirm MRSA infection much more rapidly, allowing early and effective treatment.


• Synature: a new approach to target marketing and consumer profiling, based on psychological profiling techniques online, for increased profitability and customer loyalty. Developed by a team in Cambridge.


• Aberro: a computer software tool, developed by Dr Bill Rogers of the University of Texas, that automates software testing, increases productivity and accelerates the speed at which new products can be brought to market.


Angle’s business is described as ‘IP-centric’ – that is to say, it revolves around intellectual property, wherever it originates from, rather than being based on developing the company’s own technology.


It’s an unusual model, but one that works well. The growth in Angle’s capital value comes


continued on page 42 .....


C M Y CM MY CY CMY K


Protecting innovation


Our intellectual property attorneys don’t just file patents and trade marks – they work proactively with innovative businesses nationally and internationally to identify IP assets and provide strategic advice to achieve full commercial value. We act for all types of clients: spin-outs, start-ups, SMEs, major corporations, leading academic institutions, science parks, and more.


Find out how we can help protect your innovation – contact Duncan White on 01865 397900 or visit www.marks-clerk.com


THE BUSINESS MAGAZINE – THAMES VALLEY – JULY/AUGUST 2014


www.businessmag.co.uk


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56